Sunny Hills Post Acute
SUNNY HILLS POST ACUTE in LA MIRADA, CA — inspection on May 28, 2026.
Found 3 citations. Severity: Standard violations.
Health inspections identify deficiencies that facilities must correct within required timeframes. Violations range from minor documentation issues to serious safety concerns and are subject to follow-up verification.
Inspection Findings
policy and procedure (P&P) titled, Notification of Changes, dated 12/19/2022, the P&P indicated, the
treatment.
055737 05/28/2026
Sunny Hills Post Acute 12200 LA Mirada Blvd.
LA Mirada, CA 90638
During a review of Resident 1's Minimum Data Set ([MDS], a resident assessment tool) dated, 4/2/2026, the MDS indicated Resident 1 had moderate cognitive impairment (problems with the ability to think, remember, and solve problems).
The MDS indicated Resident 1 required setup or clean-up assistance (helper sets up or cleans up) for Activities of Daily Living (ADLs) such personal hygiene and required substantial/maximal assistance (helper does more than half the effort) for ADLs such as showering/bathing self.
The MDS indicated Resident 1 required partial/moderate assistance (helper does less than half the effort) to perform movements such as rolling left and right and transferring from bed to chair.
During a review of Resident 1's Order Summary report, Resident 1's physician's order, dated 3/30/2026, indicated, Hydromorphone (also known as Dilaudid, a powerful, prescription-only pain medication used to treat severe pain) 4 milligrams ([mg], metric unit of measurement) one tablet by mouth every four (4) hours, as needed (PRN) for (7/10) severe pain (a numerical pain scale used in a facility with 0 no pain, 1-3 mild pain, 4-6 moderate pain, 7-8 severe pain, 9-10 worst pain possible) and Hydrochloric Acid (HCl) Oral Tablet 4 mg, 1 tablet by mouth every 4 hours PRN for 7-10 pain.
During a review of Resident 1's Medication Administration Record (MAR), for the month of 4/2026, the MAR indicated that on 4/8/2026 at 8:49 p.m., Resident 1 received Hydromorphone HCl 4 mg tablet for 9/10 (severe pain) pain level and 10/10 (severe pain) on 4/10/2026 at 7:52 p.m.
During a review of Resident 1's progress notes dated 4/8/2026 at 10:18 p.m., the progress notes indicated Resident 1's pain level was reassessed, and the level was 2/10 (mild pain).
The progress notes dated 4/10/2026 at 11:27 p.m., indicated Resident 1's pain level was reassessed, and the level was 1/10 (mild pain).
During a concurrent interview and record review on 5/27/2026 at 4:03 p.m., with Licensed Vocational Nurse (LVN) 3, Resident 1's MAR, dated 4/8/2026 and 4/10/2026, and progress notes dated 4/8/2026 and 4/10/2026 were reviewed. LVN 3 stated after the pain medications were administered to Resident 1 on 4/8/2026 and 4/10/2026, the facility staff should have reassessed the resident's pain level after an hour, to determine if the resident's pain has improved or not. LVN 3 stated Resident 1's progress notes indicated that on 4/8/2026 and 4/10/2026, Resident 1's pain level was reassessed more than an hour after the pain medication was administered. LVN 3 stated it was important to reassess the resident's pain level and document the reassessment to ensure that the resident's pain was managed timely.
During an interview on 6/1/2026 at 2:18 p.m., with the Director of Nursing (DON), the DON stated it was not acceptable to reassess Resident 1's pain level more than one hour after the pain medications were administered as the resident's pain level could have been unmanaged.
During a review of facility's policy and procedure (P&P) titled, Pain Management, dated 3/17/2025, the P&P indicated, the facility must ensure that pain management is provided to residents in accordance with professional standards of practice, the comprehensive person-centered care plan and the resident's goals and preferences.
055737 05/28/2026
Sunny Hills Post Acute 12200 LA Mirada Blvd.
LA Mirada, CA 90638
During a concurrent interview and record review on 6/1/2026 at 2:18 p.m., with the DON, Resident 1's MAR for Ozempic, dated 3/30/2026, the MAR for Buprenorphine Patch, dated 4/1/2026, 4/22/2026 and 4/29/2026, the facility's policy and procedures (P&P), titled Medication Ordering and Receiving from Pharmacy, dated 8/2014, and Resident 1's Progress Notes, dated 4/2026, were reviewed.
The DON stated both Ozempic on 3/30/2026 and Buprenorphine Transdermal Patch on 4/1/2026, 4/22/2026 and 4/29/2026 should not have been marked off as given, because the medications were never delivered by the pharmacy.
The nurses should have followed up with pharmacy.
The DON stated she was aware that Resident 1 did not receive the Buprenorphine Patch, and FM brought in two doses from home (date not specified).
The DON stated medications brought from home which are to be continued at the facility should be verified by the pharmacist or physician according to the facility's P&P titled Medication Ordering and Receiving from Pharmacy.
The DON stated Resident 1's progress notes did not indicate the Buprenorphine patches brought by the resident's FM was verified from the resident's PCP if approved to continue taking the medicine (Buprenorphine patch).
During a review of facility's P&P titled, Medication Administration, dated 12/19/2022, the P&P indicated to sign MAR after medications is administered, correct any discrepancies and report to nurse manager.
During a review of facility's P&P titled, Medication Ordering and Receiving From Pharmacy, dated 8/2014, the P&P indicated, the use of medications brought to the facility by a family member from home is allowed only when the physical description of the medication have been verified by a pharmacist or physician.
Frequently Asked Questions
More Reports
Source: This inspection report was downloaded directly from the Centers for Medicare & Medicaid Services (CMS) via Medicare.gov. CMS releases nursing home inspection reports in bulk. The findings reflect what state surveyors documented in the official Form CMS-2567 Statement of Deficiencies on the date of the inspection.
Plan of correction not included: The CMS report we receive does not include the facility's plan of correction. Facilities submit plans of correction separately to their state survey agency and those responses may not appear in CMS public data at the time of release. The absence of a plan of correction in this report does not mean one was not filed. Readers who want information about corrective steps taken by the facility are encouraged to contact the facility or their state survey agency directly.
Corrections may have been made: This report reflects conditions observed on the date of the survey. The facility may have implemented staffing changes, additional training, policy revisions, or other corrective actions since this report was issued. We publish what CMS provides and encourage readers to seek current information from the facility.